| MeSH term | MeSH ID | Detail |
|---|---|---|
| Arteriolosclerosis | D050379 | 1 associated lipids |
| Tooth Ankylosis | D020254 | 1 associated lipids |
| Spondylarthropathies | D025242 | 1 associated lipids |
| Musculoskeletal Diseases | D009140 | 2 associated lipids |
| Hip Fractures | D006620 | 2 associated lipids |
| No-Reflow Phenomenon | D054318 | 2 associated lipids |
| Ossification, Heterotopic | D009999 | 2 associated lipids |
| Adrenal Hyperplasia, Congenital | D000312 | 2 associated lipids |
| Angina, Stable | D060050 | 2 associated lipids |
| Sarcoma, Ewing | D012512 | 2 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Jurado S et al. | Polymorphisms and haplotypes across the osteoprotegerin gene associated with bone mineral density and osteoporotic fractures. | 2010 | Osteoporos Int | pmid:19436932 |
| Moran CS et al. | Association of PPARgamma allelic variation, osteoprotegerin and abdominal aortic aneurysm. | 2010 | Clin. Endocrinol. (Oxf) | pmid:19438902 |
| Yilmaz Y et al. | Serum levels of osteoprotegerin in the spectrum of nonalcoholic fatty liver disease. | 2010 | Scand. J. Clin. Lab. Invest. | pmid:20942739 |
| Jurado S et al. | Effect of IL-1beta, PGE(2), and TGF-beta1 on the expression of OPG and RANKL in normal and osteoporotic primary human osteoblasts. | 2010 | J. Cell. Biochem. | pmid:20225238 |
| Ma H et al. | Effects of diet-induced obesity and voluntary wheel running on bone properties in young male C57BL/6J mice. | 2010 | Calcif. Tissue Int. | pmid:20229059 |
| Jono S et al. | Serum osteoprotegerin levels and long-term prognosis in subjects with stable coronary artery disease. | 2010 | J. Thromb. Haemost. | pmid:20230427 |
| Kobayashi-Sakamoto M et al. | Osteoprotegerin induces cytoskeletal reorganization and activates FAK, Src, and ERK signaling in endothelial cells. | 2010 | Eur. J. Haematol. | pmid:20331738 |
| Chen CH et al. | Soluble receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoprotegerin in ankylosing spondylitis: OPG is associated with poor physical mobility and reflects systemic inflammation. | 2010 | Clin. Rheumatol. | pmid:20690034 |
| Lee HJ et al. | Heme oxygenase-1 protects human periodontal ligament cells against substance P-induced RANKL expression. | 2010 | J. Periodont. Res. | pmid:20337895 |
| Røysland R et al. | Prognostic value of osteoprotegerin in chronic heart failure: The GISSI-HF trial. | 2010 | Am. Heart J. | pmid:20691834 |
| Noheria A et al. | Association of serum osteoprotegerin with left ventricular mass in African American adults with hypertension. | 2010 | Am. J. Hypertens. | pmid:20339356 |
| Wiens M et al. | The role of biosilica in the osteoprotegerin/RANKL ratio in human osteoblast-like cells. | 2010 | Biomaterials | pmid:20673584 |
| Mogi M and Kondo A | ELISA for RANKL-OPG complex in mouse sera. | 2010 | J Immunoassay Immunochem | pmid:20391022 |
| Schramm HM | The role of the osteoimmune axis in the inflammation of the inner auditory ear and with regard to the putative anticarcinogenetic principle: part 2. | 2010 | Inflamm Allergy Drug Targets | pmid:20402646 |
| Vik A et al. | Relation between serum osteoprotegerin and carotid intima media thickness in a general population - the Tromsø Study. | 2010 | J. Thromb. Haemost. | pmid:20738762 |
| Bartold PM et al. | Mechanisms and control of pathologic bone loss in periodontitis. | 2010 | Periodontol. 2000 | pmid:20403105 |
| Dalbeth N et al. | Circulating mediators of bone remodeling in psoriatic arthritis: implications for disordered osteoclastogenesis and bone erosion. | 2010 | Arthritis Res. Ther. | pmid:20796300 |
| Nannuru KC et al. | Matrix metalloproteinase (MMP)-13 regulates mammary tumor-induced osteolysis by activating MMP9 and transforming growth factor-beta signaling at the tumor-bone interface. | 2010 | Cancer Res. | pmid:20406980 |
| Cody JJ et al. | Arming a replicating adenovirus with osteoprotegerin reduces the tumor burden in a murine model of osteolytic bone metastases of breast cancer. | 2010 | Cancer Gene Ther. | pmid:20798695 |
| Wu WT et al. | The association of serum osteoprotegerin and osteoporosis in postmenopausal hemodialysis patients: a pilot study. | 2010 | J Womens Health (Larchmt) | pmid:20210559 |
| Fanourakis G et al. | Expression of receptor activator of NF-κB ligand and osteoprotegerin in peripheral giant cell granulomas of the jaws. | 2010 | J. Oral Pathol. Med. | pmid:20701665 |
| Sanchez-Niño MD et al. | New paradigms in cell death in human diabetic nephropathy. | 2010 | Kidney Int. | pmid:20703212 |
| Kauther MD et al. | Biochemical markers of particle induced osteolysis in C57BL/6 mice. | 2010 | Clin. Chem. Lab. Med. | pmid:20704528 |
| Rooney T et al. | Synovial tissue rank ligand expression and radiographic progression in rheumatoid arthritis: observations from a proof-of-concept randomized clinical trial of cytokine blockade. | 2010 | Rheumatol. Int. | pmid:19847430 |
| Vanella L et al. | HO-1 expression increases mesenchymal stem cell-derived osteoblasts but decreases adipocyte lineage. | 2010 | Bone | pmid:19853072 |
| Ochi H et al. | The roles of TNFR1 in lipopolysaccharide-induced bone loss: dual effects of TNFR1 on bone metabolism via osteoclastogenesis and osteoblast survival. | 2010 | J. Orthop. Res. | pmid:19890995 |
| Jensen JK et al. | Osteoprotegerin concentrations and prognosis in acute ischaemic stroke. | 2010 | J. Intern. Med. | pmid:19895657 |
| Zupan J et al. | Gene-gene interactions in RANK/RANKL/OPG system influence bone mineral density in postmenopausal women. | 2010 | J. Steroid Biochem. Mol. Biol. | pmid:19896533 |
| Walker CG et al. | Osteopontin is required for unloading-induced osteoclast recruitment and modulation of RANKL expression during tooth drift-associated bone remodeling, but not for super-eruption. | 2010 | Bone | pmid:20828639 |
| Rianthavorn P et al. | Trabecular bone volume and osteoprotegerin expression in uremic rats given high calcium. | 2010 | Pediatr. Nephrol. | pmid:20676692 |
| Le Heron L et al. | Cystic fibrosis transmembrane conductance regulator (CFTR) regulates the production of osteoprotegerin (OPG) and prostaglandin (PG) E2 in human bone. | 2010 | J. Cyst. Fibros. | pmid:20005786 |
| Jules J et al. | Selective targeting of RANK signaling pathways as new therapeutic strategies for osteoporosis. | 2010 | Expert Opin. Ther. Targets | pmid:20678025 |
| Shead EF et al. | Osteoclast function, bone turnover and inflammatory cytokines during infective exacerbations of cystic fibrosis. | 2010 | J. Cyst. Fibros. | pmid:20006563 |
| Fong JE et al. | Tumor-supportive and osteoclastogenic changes induced by breast cancer-derived factors are reversed by inhibition of {gamma}-secretase. | 2010 | J. Biol. Chem. | pmid:20679341 |
| Kim M et al. | Td92, an outer membrane protein of Treponema denticola, induces osteoclastogenesis via prostaglandin E(2)-mediated RANKL/osteoprotegerin regulation. | 2010 | J. Periodont. Res. | pmid:20682013 |
| Lossdörfer S et al. | Aging affects the phenotypic characteristics of human periodontal ligament cells and the cellular response to hormonal stimulation in vitro. | 2010 | J. Periodont. Res. | pmid:20682014 |
| Ostrowski MC | A new role for OPG: putting RANKL in its place. | 2010 | J. Bone Miner. Res. | pmid:20684024 |
| Santos VR et al. | Receptor activator of nuclear factor-kappa B ligand/osteoprotegerin ratio in sites of chronic periodontitis of subjects with poorly and well-controlled type 2 diabetes. | 2010 | J. Periodontol. | pmid:20476881 |
| Wu XY et al. | The relationship between the levels of gonadotropic hormones and OPG, leptin, TGF-beta1 and TGF-beta2 in Chinese adult women. | 2010 | Clin. Chim. Acta | pmid:20478283 |
| Cawley NX et al. | Obese carboxypeptidase E knockout mice exhibit multiple defects in peptide hormone processing contributing to low bone mineral density. | 2010 | Am. J. Physiol. Endocrinol. Metab. | pmid:20460579 |
| Jiang R et al. | High expression levels of IKKalpha and IKKbeta are necessary for the malignant properties of liver cancer. | 2010 | Int. J. Cancer | pmid:19728335 |
| Rhee EJ et al. | The relationship between Receptor Activator of Nuclear Factor-kappaB Ligand (RANKL) gene polymorphism and aortic calcification in Korean women. | 2010 | Endocr. J. | pmid:20431232 |
| Wiwanitkit V | Osteoprotegerin and acute ischaemic stroke. | 2010 | J. Intern. Med. | pmid:20433585 |
| Qian Y and Huang HZ | The role of RANKL and MMP-9 in the bone resorption caused by ameloblastoma. | 2010 | J. Oral Pathol. Med. | pmid:20412401 |
| Qian H et al. | Activation of cannabinoid receptor CB2 regulates osteogenic and osteoclastogenic gene expression in human periodontal ligament cells. | 2010 | J. Periodont. Res. | pmid:20412420 |
| Eagan TM et al. | Body composition and plasma levels of inflammatory biomarkers in COPD. | 2010 | Eur. Respir. J. | pmid:20413541 |
| Lamoureux F et al. | Regulation of osteoprotegerin pro- or anti-tumoral activity by bone tumor microenvironment. | 2010 | Biochim. Biophys. Acta | pmid:19733222 |
| Mine Y et al. | Impact of titanium ions on osteoblast-, osteoclast- and gingival epithelial-like cells. | 2010 | J Prosthodont Res | pmid:19733525 |
| Xu DR et al. | [Significance of sRANKL/OPG ratio in diagnosis of multiple myeloma bone disease]. | 2010 | Zhongguo Shi Yan Xue Ye Xue Za Zhi | pmid:20416172 |
| Martin-Bautista E et al. | Improvement of bone formation biomarkers after 1-year consumption with milk fortified with eicosapentaenoic acid, docosahexaenoic acid, oleic acid, and selected vitamins. | 2010 | Nutr Res | pmid:20579524 |
| Tyrovola JB et al. | Relation of soluble RANKL and osteoprotegerin levels in blood and gingival crevicular fluid to the degree of root resorption after orthodontic tooth movement. | 2010 | J Oral Sci | pmid:20587957 |
| McAllister SS and Weinberg RA | Tumor-host interactions: a far-reaching relationship. | 2010 | J. Clin. Oncol. | pmid:20644094 |
| Gupta N et al. | IL-3 inhibits human osteoclastogenesis and bone resorption through downregulation of c-Fms and diverts the cells to dendritic cell lineage. | 2010 | J. Immunol. | pmid:20644169 |
| Pedersen ER et al. | Serum osteoprotegerin levels and long-term prognosis in patients with stable angina pectoris. | 2010 | Atherosclerosis | pmid:20621297 |
| Long L et al. | Dickkopf-1 as potential biomarker to evaluate bone erosion in systemic lupus erythematosus. | 2010 | J. Clin. Immunol. | pmid:20589421 |
| Odiere MR et al. | Protein deficiency and nematode infection during pregnancy and lactation reduce maternal bone mineralization and neonatal linear growth in mice. | 2010 | J. Nutr. | pmid:20660285 |
| Saito-Yabe M et al. | PEGylation of osteoprotegerin/osteoclastogenesis inhibitory factor (OPG/OCIF) results in decreased uptake into rats and human liver. | 2010 | J. Pharm. Pharmacol. | pmid:20663032 |
| Pantsulaia I et al. | Association between radiographic hand osteoarthritis and RANKL, OPG and inflammatory markers. | 2010 | Osteoarthr. Cartil. | pmid:20633673 |
| Passeri G et al. | Adhesion pattern and growth of primary human osteoblastic cells on five commercially available titanium surfaces. | 2010 | Clin Oral Implants Res | pmid:20636730 |
| Zhu LL et al. | [Concentration measurement of the OPG and sRANKL of peripheral blood among normal healthy people]. | 2010 | Zhongguo Gu Shang | pmid:20345025 |
| Jilka RL et al. | Continuous elevation of PTH increases the number of osteoblasts via both osteoclast-dependent and -independent mechanisms. | 2010 | J. Bone Miner. Res. | pmid:20533302 |
| Paternoster L et al. | OPG and RANK polymorphisms are both associated with cortical bone mineral density: findings from a metaanalysis of the Avon longitudinal study of parents and children and gothenburg osteoporosis and obesity determinants cohorts. | 2010 | J. Clin. Endocrinol. Metab. | pmid:20534768 |
| van Tuyl LH et al. | Baseline RANKL:OPG ratio and markers of bone and cartilage degradation predict annual radiological progression over 11 years in rheumatoid arthritis. | 2010 | Ann. Rheum. Dis. | pmid:20525836 |
| Zhang L et al. | Cell-based osteoprotegerin therapy for debris-induced aseptic prosthetic loosening on a murine model. | 2010 | Gene Ther. | pmid:20428210 |
| Kim YG et al. | Effect of interleukin-32gamma on differentiation of osteoclasts from CD14+ monocytes. | 2010 | Arthritis Rheum. | pmid:20112365 |
| Moreno-Rubio J et al. | Nonsteroidal antiinflammatory drugs and prostaglandin E(2) modulate the synthesis of osteoprotegerin and RANKL in the cartilage of patients with severe knee osteoarthritis. | 2010 | Arthritis Rheum. | pmid:20112374 |
| Wagner H | Bone diseases: Interferon regulatory factor-8 suppresses osteoclastogenesis. | 2010 | Nat Rev Rheumatol | pmid:20125173 |
| Jiang XY et al. | Association of LPR5 polymorphism with bone mass density and cholesterol level in population of Chinese Han. | 2010 | Exp. Clin. Endocrinol. Diabetes | pmid:20146170 |
| Stankovic KM et al. | Differences in gene expression between the otic capsule and other bones. | 2010 | Hear. Res. | pmid:20146935 |
| Krause U et al. | Pharmaceutical modulation of canonical Wnt signaling in multipotent stromal cells for improved osteoinductive therapy. | 2010 | Proc. Natl. Acad. Sci. U.S.A. | pmid:20150512 |
| Daoussis D et al. | Wnt pathway and IL-17: novel regulators of joint remodeling in rheumatic diseases. Looking beyond the RANK-RANKL-OPG axis. | 2010 | Semin. Arthritis Rheum. | pmid:19095294 |
| Appel H et al. | Immunohistochemical analysis of osteoblasts in zygapophyseal joints of patients with ankylosing spondylitis reveal repair mechanisms similar to osteoarthritis. | 2010 | J. Rheumatol. | pmid:20156950 |
| Kadoglou NP et al. | Beneficial changes of serum calcification markers and contralateral carotid plaques echogenicity after combined carotid artery stenting plus intensive lipid-lowering therapy in patients with bilateral carotid stenosis. | 2010 | Eur J Vasc Endovasc Surg | pmid:20004120 |
| Secchiero P et al. | An imbalanced OPG/TRAIL ratio is associated to severe acute myocardial infarction. | 2010 | Atherosclerosis | pmid:20015493 |
| Pal SN et al. | Osteocalcin positive mononuclear cells are associated with the severity of aortic calcification. | 2010 | Atherosclerosis | pmid:20004897 |
| Lee JE et al. | Impact of ENPP1 and MMP3 gene polymorphisms on aortic calcification in patients with type 2 diabetes in a Korean population. | 2010 | Diabetes Res. Clin. Pract. | pmid:20092902 |
| Flyvbjerg A | Diabetic angiopathy, the complement system and the tumor necrosis factor superfamily. | 2010 | Nat Rev Endocrinol | pmid:20098449 |
| Scudla V et al. | The importance of serum levels of selected biological parameters in the diagnosis, staging and prognosis of multiple myeloma. | 2010 | Neoplasma | pmid:20099972 |
| Wang J and Stern PH | Osteoclastogenic activity and RANKL expression are inhibited in osteoblastic cells expressing constitutively active Gα(12) or constitutively active RhoA. | 2010 | J. Cell. Biochem. | pmid:20872746 |
| Borsje MA et al. | Comparison of low-intensity pulsed ultrasound and pulsed electromagnetic field treatments on OPG and RANKL expression in human osteoblast-like cells. | 2010 | Angle Orthod | pmid:20050743 |
| Ruiz-Gaspà S et al. | Lithocholic acid downregulates vitamin D effects in human osteoblasts. | 2010 | Eur. J. Clin. Invest. | pmid:20055894 |
| Kochetkova EA et al. | [Osteoprotegerin and bone mineral density in patients with chronic obstructive pulmonary disease]. | 2010 | Ter. Arkh. | pmid:20873238 |
| Sypniewska G et al. | Does serum osteoprotegerin level relate to fragility fracture in elderly women with low vitamin D status? | 2010 | Med. Sci. Monit. | pmid:20110921 |
| Elias LS et al. | Markers of bone remodeling in neoplastic and bone-related lesions. | 2010 | Oral Surg Oral Med Oral Pathol Oral Radiol Endod | pmid:20955951 |
| Nozaki K et al. | Effect of cyclic mechanical loading on osteoclast recruitment in periodontal tissue. | 2010 | J. Periodont. Res. | pmid:19602121 |
| Subramaniam M et al. | TGFbeta inducible early gene-1 directly binds to, and represses, the OPG promoter in osteoblasts. | 2010 | Biochem. Biophys. Res. Commun. | pmid:20059964 |
| O'Sullivan EP et al. | Osteoprotegerin is higher in peripheral arterial disease regardless of glycaemic status. | 2010 | Thromb. Res. | pmid:20932553 |
| Corallini F et al. | TNF-alpha modulates the migratory response of mesenchymal stem cells to TRAIL. | 2010 | Cell. Mol. Life Sci. | pmid:20063037 |
| Zhang YG et al. | Effect of negative pressure on human bone marrow mesenchymal stem cells in vitro. | 2010 | Connect. Tissue Res. | pmid:20067412 |
| Norazlina M et al. | Effects of vitamin E on receptor activator of nuclear factor kappa B ligand (RANKL) and osteoprotegerin (OPG) in rats treated with nicotine. | 2010 | Med. J. Malaysia | pmid:21265240 |
| Zhang J et al. | [Effect of zoledronic acid on the differentiation and osteoprotegerin production of osteoblasts in rabbit]. | 2010 | Zhonghua Kou Qiang Yi Xue Za Zhi | pmid:21122371 |
| Salah H et al. | The clinical significance of OPG/sRANKL ratio in thalassemia patients suffering from osteopenia or osteoporosis in Egyptian patients. | 2010 | Immunol. Invest. | pmid:20718662 |
| Lee YH et al. | Associations between osteoprotegerin polymorphisms and bone mineral density: a meta-analysis. | 2010 | Mol. Biol. Rep. | pmid:19642016 |
| Eagan TM et al. | Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study. | 2010 | Eur. Respir. J. | pmid:19643942 |
| Roato I et al. | Bone impairment in phenylketonuria is characterized by circulating osteoclast precursors and activated T cell increase. | 2010 | PLoS ONE | pmid:21152388 |
| Huang FM et al. | Platelet-rich fibrin increases proliferation and differentiation of human dental pulp cells. | 2010 | J Endod | pmid:20850666 |
| Kenanidis EI et al. | Serum levels of bone turnover markers following total joint arthroplasty. | 2010 | J Orthop Surg (Hong Kong) | pmid:21187538 |
| Wang X et al. | [Association of serum follicle stimulating hormone with osteoprotegerin, leptin, TGF-β1, and TGF-β2 in women]. | 2010 | Zhong Nan Da Xue Xue Bao Yi Xue Ban | pmid:21200095 |
| Masuki H et al. | Immunolocalization of DMP1 and sclerostin in the epiphyseal trabecule and diaphyseal cortical bone of osteoprotegerin deficient mice. | 2010 | Biomed. Res. | pmid:21079361 |
| Tawfeek H et al. | Disruption of PTH receptor 1 in T cells protects against PTH-induced bone loss. | 2010 | PLoS ONE | pmid:20808842 |